Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Anti-Cancer Drugs|February 22, 2013
Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model systemDaniel R Budman, Anthony Calabro, Lisa Rosen, et al.Current Treatment Options in Oncology|April 11, 2009
Adjuvant chemotherapy for early breast cancer in the elderlyMary Leung, Iulianna Shapira, Thomas Bradley, et al.Oncology|February 28, 2009
Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature reviewBrian H Kim, Thomas Bradley, Julia Tai, et al.Anti-Cancer Drugs|July 3, 2008
In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemiaAnthony Calabro, Julia Tai, Steven L Allen, et al.Biochimica Et Biophysica Acta|May 15, 2002
WTH3, a new member of the Rab6 gene family, and multidrug resistanceJidong Shan, Liming Yuan, Daniel R Budman, et al.Cureus|August 25, 2021
Thyroid Storm-Induced Acute Liver Dysfunction and Disseminated Intravascular CoagulationYungmin Kim, Dawa Gurung, Vikram Sumbly, et al.Cureus|June 24, 2021
A Rare Case of Small Cell Lung Cancer With an Epidermal Growth Factor Receptor Mutation and Its Response to OsimertinibSakil Bhuiyan, Raheel S Siddiqui, Milana Zirkiyeva, et al.Molecular Medicine (Cambridge, Mass.)|March 23, 2011
Poly(ADP-ribose) polymerase-1 inhibition: preclinical and clinical development of synthetic lethalityMary Leung, David Rosen, Scott Fields, et al.Anti-Cancer Drugs|August 31, 2006
Identification of potentially useful combinations of epidermal growth factor receptor tyrosine kinase antagonists with conventional cytotoxic agents using median effect analysisDaniel R Budman, Richie Soong, Anthony Calabro, et al.Cancer Genetics and Cytogenetics|October 3, 2006
Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphomaLin Li, Shiphali Gupta, Tayyaba Bashir, et al.Pageof 5